Vladimir Coric

7.8k total citations · 4 hit papers
113 papers, 3.7k citations indexed

About

Vladimir Coric is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Vladimir Coric has authored 113 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Psychiatry and Mental health, 20 papers in Clinical Psychology and 19 papers in Cellular and Molecular Neuroscience. Recurrent topics in Vladimir Coric's work include Migraine and Headache Studies (46 papers), Trigeminal Neuralgia and Treatments (14 papers) and Psychosomatic Disorders and Their Treatments (13 papers). Vladimir Coric is often cited by papers focused on Migraine and Headache Studies (46 papers), Trigeminal Neuralgia and Treatments (14 papers) and Psychosomatic Disorders and Their Treatments (13 papers). Vladimir Coric collaborates with scholars based in United States, United Kingdom and Canada. Vladimir Coric's co-authors include Robert Croop, Christopher Pittenger, Richard B. Lipton, Michael H. Bloch, John H. Krystal, Elyse Stock, Charles M. Conway, David Stock, Ben Kelmendi and Peter J. Goadsby and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Vladimir Coric

104 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial

2019 276 citations Robert Croop, Peter J. Goadsby et al. The Lancet profile →
Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine

2019 265 citations Richard B. Lipton, Robert Croop et al. profile →
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

2020 233 citations Robert Croop, Richard B. Lipton et al. The Lancet profile →
Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial

2023 85 citations Richard B. Lipton, Robert Croop et al. profile →

Peers

Countries citing papers authored by Vladimir Coric

Since Specialization

Citations

This map shows the geographic impact of Vladimir Coric's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Coric with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Coric more than expected).

Fields of papers citing papers by Vladimir Coric

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Coric. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Coric. The network helps show where Vladimir Coric may publish in the future.

Co-authorship network of co-authors of Vladimir Coric

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Coric. A scholar is included among the top collaborators of Vladimir Coric based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Coric. Vladimir Coric is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Troriluzole rescues glutamatergic deficits, amyloid and tau pathology, and synaptic and memory impairments in 3xTg ‐ AD mice 2024 ·Journal of Neurochemistry ·(unknown), Priyanka D. Pinky, (unknown), (unknown), (unknown), Vishnu Suppiramaniam, Vladimir Coric, Irfan Qureshi, Michael W. Gramlich, Miranda N. Reed	4
2	Next Generation Prodrug Troriluzole: Increased Bioavailability of Riluzole with No Food Effect in Healthy Subjects (S5.006) 2024 ·Neurology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Stephen Kaplita, (unknown), Elizabeth K. Hussey, Irfan Qureshi, Vladimir Coric, Richard Bertz	0
3	Re-weighting MDS-UPDRS Motor Items for Optimal Sensitivity to Parkinson’s Disease Progression in Untreated Patients Using Parkinson’s Progression Markers Initiative Data (S2.004) 2024 ·Neurology ·Gilbert L’Italien, Samuel P. Dickson, (unknown), Jordan Dubow, (unknown), Lauren Powell, Michele Potashman, (unknown), (unknown), Ellen Korol, (unknown), (unknown), Vladimir Coric, Suzanne Hendrix	0
4	Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc Analysis 2024 ·Neurology and Therapy ·Gilbert L’Italien, Evangelos K. Oikonomou, Rohan Khera, Michele Potashman, (unknown), Grant Maclaine, Jeremy D. Schmahmann, Susan B. Perlman, Vladimir Coric	6
5	POSC202 Estimated Migraine Patient Population in England Progressing Beyond First-Line Acute Management 2022 ·Value in Health ·Linda Harris, Gilbert L’Italien, Robert Croop, Vladimir Coric, James M. Robbins, (unknown), (unknown)	1
6	Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials (2091) 2020 ·Neurology ·Jelena Pavlović, David W. Dodick, Lawrence C. Newman, Richard B. Lipton, Elyse Stock, Alexandra Thiry, Charles M. Conway, (unknown), Beth Morris, Vladimir Coric, Robert Croop	1
7	Cardiovascular Safety of Rimegepant 75 mg in 3 Randomized Clinical Trials and Systematic Evaluations from In Vitro, Ex Vivo, and In Vivo Nonclinical Assays (2141) 2020 ·Neurology ·Charles M. Conway, Robert Croop, Gene M. Dubowchik, Vladimir Coric, Richard B. Lipton	12
8	Rimegepant Has No Clinically Relevant Effect on ECG parameters at Therapeutic and Supratherapeutic Doses: A Thorough QT Study Versus Placebo and Moxifloxacin in Healthy Subjects (2117) 2020 ·Neurology ·Michael Hanna, Vladimir Coric, Joseph Stringfellow, (unknown), Robert Croop	2
9	Rimegepant 75 mg Demonstrates Safety and Tolerability Similar to Placebo With No Effects of Age, Sex, or Race in 3 Phase 3 Trials (1609) 2020 ·Neurology ·Jack Schim, Susan Hutchinson, Richard B. Lipton, Elyse Stock, Alexandra Thiry, Charles M. Conway, (unknown), Beth Morris, Vladimir Coric, Robert Croop	1
10	Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial breakdown → 2020 ·The Lancet ·Robert Croop, Richard B. Lipton, David Kudrow, David Stock, Lisa Kamen, Charles M. Conway, Elyse Stock, Vladimir Coric, Peter J. Goadsby	233
11	Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial breakdown → 2019 ·The Lancet ·Robert Croop, Peter J. Goadsby, David Stock, Charles M. Conway, Micaela Forshaw, Elyse Stock, Vladimir Coric, Richard B. Lipton	276
12	A Phase 1 Study to Evaluate Bioequivalence Between BHV-0223 40 mg Zydis® Sublingual Formulation and Riluzole 50 mg Oral Tablet in Healthy Volunteers (S5.005) 2019 ·Neurology ·Irfan Qureshi, Vladimir Coric, (unknown), Richard Larouche, (unknown), Robert Berman	1
13	Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder 2015 ·The Journal of Clinical Psychiatry ·Christopher Pittenger, Michael H. Bloch, Suzanne Wasylink, Eileen Billingslea, (unknown), Ewgeni Jakubovski, Ben Kelmendi, Gerard Sanacora, Vladimir Coric	57
14	Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder 2010 ·Depression and Anxiety ·Vladimir Coric, Howard Feldman, Dan A. Oren, Anantha Shekhar, Joseph Pultz, Randy Dockens, Xiaoling Wu, (unknown), Shu-Pang Huang, (unknown), Terrye Delmonte, (unknown), Daniel L. Zimbroff, Jack A. Grebb, Andrew W. Goddard, Elyse Stock	136
15	Glutamatergic dysfunction in obsessive-compulsive disorder and the potential clinical utility of glutamate-modulating agents 2006 ·Christopher Pittenger, Michael H. Bloch, Ryan Wegner, (unknown), John H. Krystal, Vladimir Coric	11
16	Self-reported paranoia during laboratory “binge” cocaine self-administration in humans 2006 ·Pharmacology Biochemistry and Behavior ·Rasmon Kalayasiri, Atapol Sughondhabirom, Ralitza Gueorguieva, Vladimir Coric, Wendy J. Lynch, Peter Morgan, Joseph F. Cubells, Robert T. Malison	37
17	Relation between cardiac vagal tone and performance in male military personnel exposed to high stress: Three prospective studies 2006 ·Psychophysiology ·Charles A. Morgan, Deane E. Aikins, (unknown), Vladimir Coric, Steven M. Southwick	45
18	A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder 2006 ·Molecular Psychiatry ·Michael H. Bloch, Angeli Landeros‐Weisenberger, Ben Kelmendi, Vladimir Coric, Michael B. Bracken, James F. Leckman	391
19	A paradigm to investigate the self-regulation of cocaine administration in humans 2005 ·Psychopharmacology ·Atapol Sughondhabirom, Diwakar Jain, Ralitza Gueorguieva, Vladimir Coric, Robert Berman, Wendy J. Lynch, David W. Self, Peter Jatlow, Robert T. Malison	33
20	Carbon monoxide poisoning and treatment with hyperbaric oxygen in the subacute phase 1998 ·Journal of Neurology Neurosurgery & Psychiatry ·Vladimir Coric, Dan A. Oren, (unknown), (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact